These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 7158363)

  • 1. Comparative bioavailability of Verospiron and Aldactone tablets in humans.
    János C; László V; Sándor KF; Zsolt S; Gabor R
    Acta Pharm Hung; 1982 Nov; 52(6):274-79. PubMed ID: 7158363
    [No Abstract]   [Full Text] [Related]  

  • 2. The bioavailability of spironolactone hydrochlorothiazide combination preparation.
    Rameis H; Hitzenberger G; Horwatitsch H
    Int J Clin Pharmacol Ther Toxicol; 1982 Jul; 20(7):327-33. PubMed ID: 7107086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Intersubject comparison of the bioavailability of spironolactone in 2 pharmaceutical dosage forms].
    Lucchelli PD; Monarca A; Del Mastro S; Sega R
    Boll Chim Farm; 1978 Aug; 117(8):487-95. PubMed ID: 743391
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of micronization on the bioavailability and pharmacologic activity of spironolactone.
    McInnes GT; Asbury MJ; Ramsay LE; Shelton JR; Harrison IR
    J Clin Pharmacol; 1982; 22(8-9):410-7. PubMed ID: 7130430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparative bioavailability of two forms of spironolactone. Rationalization applied to dosage (author's transl)].
    d'Athis P; Richard MO; de Lauture D; Rey E; Bouvier d'Yvoire M; Clement E; Olive G
    Therapie; 1981; 36(4):443-9. PubMed ID: 7292427
    [No Abstract]   [Full Text] [Related]  

  • 6. [Biological availability of spironolactone in two different galenic forms (author's transl)].
    Rameis H; Hitzenberger G; Horwatitsch H
    Dtsch Med Wochenschr; 1979 Jun; 104(24):881-3. PubMed ID: 446311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors influencing comparative bioavailability of spironolactone tablets.
    Clarke JM; Ramsay LE; Shelton JR; Tidd MJ; Murray S; Palmer RF
    J Pharm Sci; 1977 Oct; 66(10):1429-32. PubMed ID: 579186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The bioavailability of two new preparations of spironolactone tablets.
    Nijkerk AJ; Vermeer JM; Imanse M; De Vos D
    Pharm Weekbl Sci; 1983 Oct; 5(5):210-2. PubMed ID: 6646986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Bioavailability studies of two spironolactone-preparations (author's transl)].
    Vergin H; Nuss U; Schwarzländer F; Strobel K; Weigand W; Hitzenberger G
    Arzneimittelforschung; 1981; 31(9):1498-503. PubMed ID: 7197963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparative bioavailability of prednisone and prednisone acetate tablets].
    Jia YR; Zhou BY; Zhou WB; Lei YD; Zhou Q
    Sichuan Yi Xue Yuan Xue Bao; 1985 Sep; 16(3):259-61. PubMed ID: 3837381
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparative bioavailability of two uncoated aminophylline tablets.
    Kwok F; Kradjan WA; Lakshminarayan S; Delaney C
    Am J Hosp Pharm; 1980 Dec; 37(12):1618, 1620. PubMed ID: 7446536
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effect of veroshpiron on hormone level in patients with Parkinson's disease].
    Karimova MKh; Vartanian KZ; Petelin LS; Kubatiev AA
    Klin Med (Mosk); 1994; 72(4):36-9. PubMed ID: 7990375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hypotensive effect of spironolactone in patients with essential hypertension and aldosterone regulation disorders].
    Wambach G; Helber A; Bönner G; Hummerich W; Meurer KA; Kaufmann W
    Med Welt; 1980 Aug; 31(31-32):1135-7. PubMed ID: 7421547
    [No Abstract]   [Full Text] [Related]  

  • 14. Relative bioavailability of iron from two different iron tablets used in the Indonesian Iron Supplementation Program.
    Thorand B; Pietzik K; Dillon D; Schultink W; Gross R
    Southeast Asian J Trop Med Public Health; 1993 Dec; 24(4):624-30. PubMed ID: 7939931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of formulation on dissolution and bioavailability of phenytoin tablets.
    Chakrabarti S; Belpaire F; Moerman E
    Pharmazie; 1980; 35(10):627-9. PubMed ID: 7454745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of metabolites--a new approach to bioequivalence studies of spironolactone formulations.
    Vergin H; Mahr G; Metz R; Eichinger A; Nitsche V; Martens H
    Int J Clin Pharmacol Ther; 1997 Aug; 35(8):334-40. PubMed ID: 9266289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics and bioavailability of a metformin/glyburide tablet administered alone and with food.
    Marathe PH; Arnold ME; Meeker J; Greene DS; Barbhaiya RH
    J Clin Pharmacol; 2000 Dec; 40(12 Pt 2):1494-502. PubMed ID: 11185672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative bioavailability studies on different cimetidine preparations.
    Vereczkey L; Kozma M; Kerpel-Fronius S
    Acta Pharm Hung; 1985 Jul; 55(4):217-20. PubMed ID: 4050449
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparative bioavailability of sustained-release and uncoated aspirin tablets.
    Karahalios WJ; Sawyer WT; Rittase RA; Maynard SA
    Am J Hosp Pharm; 1981 Nov; 38(11):1754-6. PubMed ID: 7304632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relative bioavailability of DL-oxyfedrine HCl after single-dose oral administration of tablets as compared to equimolar solutions.
    Wetzelsberger N; Birkel M; Fuder H; Lücker PW; Stiegler S; Scheithauer S; Thümmler D
    Methods Find Exp Clin Pharmacol; 1995 Apr; 17(3):185-91. PubMed ID: 8531509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.